Dr Reddy’s plans clinical trials of Sputnik Light for children, use as booster dose, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The drug maker said it is in the midst of finalising the protocol to begin the trials on children and adolescents which will have two cohorts one for 12-18 years and 2-12 years age groups. “The dosing requirement is likely to be different for two cohorts,” said Deepak Sapra, CEO of API & Services, Dr Reddy’s, to media., The drug maker said it is in the midst of finalising the protocol to begin the trials on children and adolescents which will have two cohorts one for 12-18 years and 2-12 years age groups. “The dosing requirement is likely to be different for two cohorts,” said Deepak Sapra, CEO of API & Services, Dr Reddy’s, to media., , Read More